JPRN-UMIN000013310
Recruiting
Phase 2
Phase II Study of Nab-paclitaxel and Carboplatin Plus Bevacizumab as First-Line Chemotherapy for Reccurent or stage IIIB and IV Nonsquamous Non-Small-Cell Lung Cancer (ALCT004) - Phase II Study of Nab-PTX and CBDCA Plus Bev With Maintenance Bev As First-Line Chemotherapy for Reccurent or Advanced Non-sq NSCLC (ALCT004)
Kyorin University School of Medicine0 sites33 target enrollmentMarch 3, 2014
Conditionson-squamous non-small-cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-squamous non-small-cell lung cancer
- Sponsor
- Kyorin University School of Medicine
- Enrollment
- 33
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)SVC synd 2\)Active concomitant malignancy except carcinoma in situ, intra\-mucosal carcinoma or cancer with more than 5 year disease free 3\)Severe active infection and sever complication (gastrointestinal hemorrhage,cardiac disease) 4\)Pregnant status or lactation 5\)Uncontrolled psychiatric disease 6\)History of allergic reaction for agents of present treatment 7\)Massive pleural effusion, peritoneal effusion or cardiac effusion required for tube drainage 8\)A history of significant hemoptysis (\> 2\.5 mL red blood per episode) before enrolment 9\)Evidence of tumor invading large vessel on imaging, cavity and thrombus 10\)History of thromboembolic events.Any history of cerebral, myocardial, and pulmonary infarction 11\)Symptomatic brain metastasis 12\)History of operation and biopsy within 4 weeks 13\)Need to antiplatelet therapy or anticoagulation therapy without Aspirin 324 mg/day within 10 days 14\)Bleeding tendency, blood coagulation disorder 15\)Bowel obstruction 16\)Current or previous history of gastrointestinal perforation and diverticulitis 17\)Pulmonary fibrosis and interstitial pneumonia on chest X\-ray or symptomatic pulmonary fibrosis and interstitial pneumonia 18\)Uncontrolled hypertension and diabetes 19\)Other ineligible status judged by medical oncologist
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancerJPRN-UMIN000011681Gifu Municipal Hospital32
Recruiting
Phase 1
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
Completed
Phase 2
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
Completed
Phase 1
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancernon small cell lung cancerJPRN-UMIN000013223Kochi University12